Review



primary antibodies against ripk4  (Abcam)


Bioz Verified Symbol Abcam is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    Abcam primary antibodies against ripk4
    <t>RIPK4</t> was a direct target of miR-330-3p in ES-2 cells. (a) The binding sites between RIPK4 and miR-330-3p predicted by TargetScan. (b)The binding relationship of RIPK4 to miR-330-3p validated by dual-luciferase reporter gene assay, * P < 0.05. The expression level of RIPK4 was detected using RT-qPCR (c) and western blot (d-e), * P < 0.05
    Primary Antibodies Against Ripk4, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 306 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+ripk4/pmc08291835-77-0-5?v=Abcam
    Average 99 stars, based on 306 article reviews
    primary antibodies against ripk4 - by Bioz Stars, 2026-07
    99/100 stars

    Images

    1) Product Images from "MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4"

    Article Title: MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4

    Journal: Bioengineered

    doi: 10.1080/21655979.2021.1871817

    RIPK4 was a direct target of miR-330-3p in ES-2 cells. (a) The binding sites between RIPK4 and miR-330-3p predicted by TargetScan. (b)The binding relationship of RIPK4 to miR-330-3p validated by dual-luciferase reporter gene assay, * P < 0.05. The expression level of RIPK4 was detected using RT-qPCR (c) and western blot (d-e), * P < 0.05
    Figure Legend Snippet: RIPK4 was a direct target of miR-330-3p in ES-2 cells. (a) The binding sites between RIPK4 and miR-330-3p predicted by TargetScan. (b)The binding relationship of RIPK4 to miR-330-3p validated by dual-luciferase reporter gene assay, * P < 0.05. The expression level of RIPK4 was detected using RT-qPCR (c) and western blot (d-e), * P < 0.05

    Techniques Used: Binding Assay, Luciferase, Reporter Gene Assay, Expressing, Quantitative RT-PCR, Western Blot

    Overexpression of RIPK4 antagonized the effects of miR-330-3p on ES-2 cells. The inhibition effect of miR-330-3p on RIPK4 expression was rescued by RIPK4 overexpression detected using RT-qPCR (a) and western blot (b), * P < 0.05. The inhibition effect of miR-330-3p on cell proliferation, migration and invasion was partly reversed by RIPK4 overexpression detected using MTT (c) and transwell assay(d), * P < 0.05
    Figure Legend Snippet: Overexpression of RIPK4 antagonized the effects of miR-330-3p on ES-2 cells. The inhibition effect of miR-330-3p on RIPK4 expression was rescued by RIPK4 overexpression detected using RT-qPCR (a) and western blot (b), * P < 0.05. The inhibition effect of miR-330-3p on cell proliferation, migration and invasion was partly reversed by RIPK4 overexpression detected using MTT (c) and transwell assay(d), * P < 0.05

    Techniques Used: Over Expression, Inhibition, Expressing, Quantitative RT-PCR, Western Blot, Migration, Transwell Assay

    The expression of RIPK4 was inversely correlated with miR-330-3p expression in OV tissues
    Figure Legend Snippet: The expression of RIPK4 was inversely correlated with miR-330-3p expression in OV tissues

    Techniques Used: Expressing



    Similar Products

    primary antibodies against ripk4  (Abcam)
    99
    Abcam primary antibodies against ripk4
    <t>RIPK4</t> was a direct target of miR-330-3p in ES-2 cells. (a) The binding sites between RIPK4 and miR-330-3p predicted by TargetScan. (b)The binding relationship of RIPK4 to miR-330-3p validated by dual-luciferase reporter gene assay, * P < 0.05. The expression level of RIPK4 was detected using RT-qPCR (c) and western blot (d-e), * P < 0.05
    Primary Antibodies Against Ripk4, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+antibodies+against+ripk4/pmc08291835-77-0-5?v=Abcam
    Average 99 stars, based on 1 article reviews
    primary antibodies against ripk4 - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    RIPK4 was a direct target of miR-330-3p in ES-2 cells. (a) The binding sites between RIPK4 and miR-330-3p predicted by TargetScan. (b)The binding relationship of RIPK4 to miR-330-3p validated by dual-luciferase reporter gene assay, * P < 0.05. The expression level of RIPK4 was detected using RT-qPCR (c) and western blot (d-e), * P < 0.05

    Journal: Bioengineered

    Article Title: MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4

    doi: 10.1080/21655979.2021.1871817

    Figure Lengend Snippet: RIPK4 was a direct target of miR-330-3p in ES-2 cells. (a) The binding sites between RIPK4 and miR-330-3p predicted by TargetScan. (b)The binding relationship of RIPK4 to miR-330-3p validated by dual-luciferase reporter gene assay, * P < 0.05. The expression level of RIPK4 was detected using RT-qPCR (c) and western blot (d-e), * P < 0.05

    Article Snippet: Primary antibodies against RIPK4 (ab203541, Abcam, Cambridge, UK) and GAPDH (ab8245, Abcam, Cambridge, UK) were utilized in this study.

    Techniques: Binding Assay, Luciferase, Reporter Gene Assay, Expressing, Quantitative RT-PCR, Western Blot

    Overexpression of RIPK4 antagonized the effects of miR-330-3p on ES-2 cells. The inhibition effect of miR-330-3p on RIPK4 expression was rescued by RIPK4 overexpression detected using RT-qPCR (a) and western blot (b), * P < 0.05. The inhibition effect of miR-330-3p on cell proliferation, migration and invasion was partly reversed by RIPK4 overexpression detected using MTT (c) and transwell assay(d), * P < 0.05

    Journal: Bioengineered

    Article Title: MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4

    doi: 10.1080/21655979.2021.1871817

    Figure Lengend Snippet: Overexpression of RIPK4 antagonized the effects of miR-330-3p on ES-2 cells. The inhibition effect of miR-330-3p on RIPK4 expression was rescued by RIPK4 overexpression detected using RT-qPCR (a) and western blot (b), * P < 0.05. The inhibition effect of miR-330-3p on cell proliferation, migration and invasion was partly reversed by RIPK4 overexpression detected using MTT (c) and transwell assay(d), * P < 0.05

    Article Snippet: Primary antibodies against RIPK4 (ab203541, Abcam, Cambridge, UK) and GAPDH (ab8245, Abcam, Cambridge, UK) were utilized in this study.

    Techniques: Over Expression, Inhibition, Expressing, Quantitative RT-PCR, Western Blot, Migration, Transwell Assay

    The expression of RIPK4 was inversely correlated with miR-330-3p expression in OV tissues

    Journal: Bioengineered

    Article Title: MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4

    doi: 10.1080/21655979.2021.1871817

    Figure Lengend Snippet: The expression of RIPK4 was inversely correlated with miR-330-3p expression in OV tissues

    Article Snippet: Primary antibodies against RIPK4 (ab203541, Abcam, Cambridge, UK) and GAPDH (ab8245, Abcam, Cambridge, UK) were utilized in this study.

    Techniques: Expressing